| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a8e20137e10efebd66f7b326dc42151 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5418 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 |
| filingDate |
2018-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0a76dbfffa8290c947273d5ac15a6db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2a58606a34546a17403f620eccc9fbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92725d87e0f6c4d99adbf7a966c7bedb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc35f885448209f173fd4d8d4ec6dab8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3609be578525a47bbe9fbde5d3dacdc8 |
| publicationDate |
2018-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201841944-A |
| titleOfInvention |
4-1BBL variant and fusion protein comprising the same |
| abstract |
The present invention relates to a novel 4-1BBL variant and a fusion protein comprising the same. The 4-1BBL variant of the invention is capable of forming a structurally stable trimer. Thus, the 4-1BBL variant trimer can efficiently bind to 4-1BB in an individual. Further, when various active proteins are combined with the 4-1BBL variant trimer, they can be used as an anticancer composition or a composition for preventing or treating an infectious disease. |
| priorityDate |
2017-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |